SabinaSignorettiMD

Clinical Molecular Genetics

Physician

Dr. Signoretti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
75 Francis St
Boston, MA 02115
Phone+1 617-525-7437

Fax+1 617-264-5169

MA State Medical License 2017 - 2025
American Board of Medical Genetics and Genomics Clinical Molecular Genetics and Genomics

PubMed

313 citations
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
Hyejin Cho, Xinlin Du, James P. Rizzi, Ella Liberzon, Abhishek A. Chakraborty
Nature. 2016-11-03
639 citations
Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion
Arnold H. Zea, Paulo C. Rodriguez, Michael B. Atkins, Claudia Hernandez, Sabina Signoretti
Cancer Research. 2005-04-15
235 citations
Association of PD-L1 Expression on Tumor Infiltrating Mononuclear Cells and Overall Survival in Patients with Urothelial Carcinoma
Joaquim Bellmunt, Stephanie A. Mullane, Lillian Werner, André P. Fay, Marcella Callea
Annals of Oncology. 2015-01-18

Journal Articles

Genomic Correlates of Response to Immune Checkpoint Blockade in Microsatellite-Stable Solid Tumors
Jeffrey A Engelman, David A Barbie, Nicole G Chau, Glenn J Hanna, Natalie I Vokes, Sabina Signoretti, Pasi A Janne, Robert I Haddad, Lynette M Sholl, Rizwan Haq, Peter..., Nature

Study Reveals Factors Influencing Outcomes in Kidney Cancer Treated with ImmunotherapyMay 29th, 2020